1. Home
  2. Analysis
  3. Lorcet-hd
  4. Levemir

Lorcet-hd and Levemir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Lorcet-hd and Levemir together.

The phase IV clinical study analyzes what interactions people who take Lorcet-hd and Levemir have. It is created by eHealthMe based on reports of 4 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 01, 2023

4 people who take Lorcet-hd and Levemir together, and have interactions are studied.

What is Lorcet-hd?

Lorcet-hd has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 2,221 Lorcet-hd users for its effectiveness, alternative drugs and more.

What is Levemir?

Levemir has active ingredients of insulin detemir recombinant. It is often used in diabetes. eHealthMe is studying from 13,832 Levemir users for its effectiveness, alternative drugs and more.

Number of Lorcet-hd and Levemir reports submitted per year:

Lorcet-hd and Levemir drug interactions.

Common Lorcet-Hd and Levemir drug interactions by gender *:

female:

  1. Pancreatitis
  2. Abdominal distension
  3. Abdominal pain
  4. Abdominal pain upper
  5. Asthenia
  6. Blood glucose increased
  7. Blood pressure increased
  8. Dehydration
  9. Diarrhoea
  10. Heart rate increased

male:

  1. Amnesia
  2. Arthralgia
  3. Cardioactive drug level below therapeutic
  4. Cardiomegaly
  5. Cerebral microangiopathy
  6. Chest discomfort
  7. Chest pain
  8. Chronic obstructive pulmonary disease
  9. Cough
  10. Depression

Common Lorcet-Hd and Levemir drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Weight decreased
  2. Amnesia
  3. Arthralgia
  4. Asthma
  5. Balance disorder
  6. Blood glucose increased
  7. Blood pressure diastolic increased
  8. Blood pressure systolic decreased
  9. Bronchitis
  10. Burning sensation

50-59:

  1. Abdominal distension
  2. Hepatomegaly
  3. Lipase increased
  4. Lipids increased
  5. Musculoskeletal chest pain
  6. Nausea
  7. Pancreatitis
  8. Pruritus
  9. Splenomegaly
  10. Visual acuity reduced

60+:

  1. Meningitis aseptic

* Approximation only. Some reports may have incomplete information.

Do you take Lorcet-hd and Levemir?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Lorcet-hd and Levemir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lorcet-hd side effects:

Browse all side effects of Lorcet-hd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levemir side effects:

Browse all side effects of Levemir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lorcet-hd interactions:

Browse all interactions between Lorcet-hd and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levemir interactions:

Browse all interactions between Levemir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate and insulin detemir recombinant (the active ingredients of Lorcet-hd and Levemir, respectively), and Lorcet-hd and Levemir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Lorcet-hd and Levemir.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.